Statement on the agency’s continued efforts to protect women’s health and enhance safety information available to patients considering breast implants

October 23, 2019 – The U.S. Food and Drug Administration is taking another significant step in protecting women’s health by helping to ensure patients have complete information about the benefits and risks of breast implants. In a draft guidance issued today, we are providing proposed labeling recommendations to manufacturers of these devices to help ensure women receive and understand information regarding the benefits and risks of breast implants. The draft … (leggi tutto)